Acelrx Pharmaceuticals reported $-43021000 in Equity Capital and Reserves for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acelrx Pharmaceuticals ACRX:US $ -43.02M 7.03M
Acura Pharmaceuticals ACUR:US 382K 6.52M
Baxter International BAX:US $ 8770M 276M
Becton, Dickinson and BDX:US $ 23677M 458M
Biodelivery Sciences International BDSI:US $ 122.78M 8.86M
Cara Therapeutics CARA:US $ 207.19M 3.72M
Heron Therapeutics HRTX:US $ 118.84M 41.27M
Intra Cellular Therapies ITCI:US $ 486.76M 66.83M
Pain Therapeutics PTIE:US $ 267.56M 8.91M
Smiths SMIN:LN 2.4B 172M
Teva Pharmaceutical TEVA:IT 10.47B 143M
Xeris Pharmaceuticals Inc XERS:US $ -2461000 22.35M
Zogenix ZGNX:US $ 224.3M 48.56M